Sanctuary Advisors’s Avita Medical RCEL Stock Holding History

Sanctuary Advisors’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-17,099	Closed	-$59K	–	2609
2025 Q4	$59K	Sell	17,099 -6,996	-29%	-$27.9K	﹤0.01%	2377
2025 Q3	$123K	Buy	+24,095	New	+$126K	﹤0.01%	2324

Other funds holding RCEL

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Sanctuary Advisors's RCEL Position: Q1 2026 in Review

Sanctuary Advisors sold out of Avita Medical (RCEL) in Q1 2026, closing a stake of 17,099 shares — an estimated $59K sold.

Sanctuary Advisors first reported a position in RCEL in Q3 2025 and held it in 2 quarters. The position peaked at $123K in Q3 2025. 79 funds tracked by Wall St. Rank hold RCEL as of Q1 2026.

Sanctuary Advisors reported no remaining Avita Medical position as of Q1 2026 after selling out during the quarter.
Sanctuary Advisors sold 17,099 Avita Medical shares in Q1 2026, an estimated $59K.
Sanctuary Advisors first reported a position in Avita Medical in Q3 2025 and held it in 2 quarters.
Sanctuary Advisors's Avita Medical position peaked at $123K in Q3 2025.
79 funds tracked by Wall St. Rank held Avita Medical as of Q1 2026.

Based on Sanctuary Advisors's 13F filing for Q1 2026, filed 5 May 2026.